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Summary 
A number of inflammatory disease states occur with greatly increased frequency in individuals 
inheriting the human major histocompatibility complex class I allele HLA-B2Z  In a minority 
of cases, namely those with B27-associated reactive arthritis,  there is good evidence that the dis- 
ease state is triggered by infection with an enteric or genitourinary bacterial pathogen. For the 
majority of B27-associated disease, no definite pathogenetic role for bacteria has been established. 
However, in these latter cases intestinal inflammation can often be demonstrated, and it some- 
times occupies a major part of the clinical picture. Rats transgenic for B27 are known to develop 
a disorder resembling B27-associated human disease, with prominent intestinal, joint, skin, and 
male genital inflammatory lesions. We report here that B27 transgenic rats raised in a germfree 
environment do not develop inflammatory intestinal or peripheral joint disease, whereas the skin 
and genital inflammatory lesions are unaffected by the germfree state. These findings support 
the concept that gut and joint inflammation are pathogenetically closely related, and they pro- 
vide direct evidence that the commensal gut flora play an important role in the pathogenesis 
of B27-associated gut and joint inflammation. 
A-B27 is strikingly associated  with the disorders termed 
pondyloarthropathies (for reviews see references 1 and 
2). These disorders are recognized clinically largely on the 
basis of  joint inflammation, and they are therefore classified 
as rheumatic diseases. However, a large body of evidence sug- 
gests an intimate involvement of intestinal inflammation in 
the pathogenesis  of these disorders. This evidence includes 
triggering of B27-associated reactive arthritis by certain en- 
teric pathogens (3), increased prevalence of ankylosing spon- 
dylitis and peripheral arthritis in patients with inflammatory 
bowel disease (4, 5), increased prevalence of inflammatory 
bowel disease in family members of patients with ankylosing 
spondylitis  (6), acute intestinal  inflammation occurring in 
the setting of reactive arthritis  arising from genitourinary 
A portion of this work has been reported in abstract form (1993. Arthritis 
Rheum. 36:$46; 1994. FASEB [Fed. Am. Soc Ext~ Biol.] J.  8:A968). 
infection (3, 7), the presence of microscopic bowel inflam- 
mation in a high proportion of patients with B27-associated 
rheumatic disease (8,  9),  antigenic and  structural  cross- 
reactivity between the HLA-B27 molecule and components 
of enteric bacteria (10, 11), diminished internalization of en- 
teric bacteria by cultured fibroblasts expressing HLA-B27 (12), 
and triggering of inflammatory arthritis in animals by ex- 
perimental  injection of peptidoglycan  from normal bowel 
flora (13). 
This intimate association between the gastrointestinal tract 
and the spondyloarthropathies  is reproduced in transgeuic 
rats expressing HLA-B27, in which gut and joint inflamma- 
tion are prominent aspects of a spontaneous multisystem dis- 
ease that resembles the human spondyloarthropathies  (2, 14, 
15). Because of the evidence for a potential role for intestinal 
flora in the pathogenesis of B27-associated disease, we inves- 
tigated the effect of the germfree state on the inflammatory 
disease of B27 transgenic rats. Here we report the results of 
these studies. 
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Derivation and Maintenance  of  Germfree Rats.  The transgenic rat 
lines 33-3 (F344 strain) and 21-4H (LEW strain) expressing genes 
for HLA-B*2705 and human 32-microglobulin have been previ- 
ously described (2, 14). One litter of each line was rederived by 
cesarean section into a germfree environment at the University of 
Wisconsin Gnotobiote Laboratory. These rats and their descendants 
were maintained in  this environment  and observed for disease 
manifestations as described (14). Weekly stoolexaminations for aer- 
obic and anaerobic bacteria, parasites and fungi, and serology for 
eight viruses, were uniformly negative. Rats were shipped to the 
University of Texas Southwestern Medical Center for necropsy or 
for transfer to a nongermfree environment. Rats were shipped in 
germfree containers and maintained under sterile conditions until 
killing or transfer to a nongermfree colony, with the exception of 
one shipment of nine rats shipped in nongermfree containers. 
Nongermfree  Rats.  Rats not housed under germfree conditions 
were kept either in a specific pathogen-free barrier facility or in 
a conventional room. 
Northern Blotting.  This was carried out as previously described 
(2, 14). Hepatic cd-acid glycoprotein (cd-AGP) transcripts were 
identified with an 850-bp rat od-AGP cDNA fragment (16) (gift 
of Dr. H. Baumann, Roswell Park Cancer Institute, Buffalo, NY). 
Histology, Imrnunocytochemistry,  and Flow Cytometry.  These were 
carried out as previously described (2, 14). 
Results 
Protection from Gut Inflammation.  37 transgenic rats (19 
21-4H and 18 33-3) and 17 nontransgenic littermates (six LEW 
and 11 F344) were observed under germfree conditions for 
23-66 wk. None of these germfree rats showed any evidence 
of diarrhea, a prominent finding by the age of 20 wk in these 
transgenic lines when housed under nongermfree conditions 
(14). Necropsies were performed on 17 germfree 21-4H rats 
and 13 germfree 33-3 rats, and also on six nontransgenic germ- 
free littermates (three LEW, three F344).  All 36 rats showed 
massive cecal enlargement at necropsy, a well-established sign 
of the germfree state in rodents that reverses rapidly after as- 
sociation with  gastrointestinal flora (17). One  58-wk-old 
germfree transgenic 21-4H rat showed a peculiar thickening 
of the large and small intestinal wall, but was free of diarrhea. 
Histologically, the colons of these rats showed shallow 
crypts, another previously described sign of the germfree state 
in rodents (18). Some of the transgenic colon sections showed 
a subtle hypercellularity within the lamina propria and slight 
elongation of crypt height, in comparison with the nontrans- 
genic germfree sections,  but no inflammatory lesions were 
evident and none of the sections appeared outside the range 
of normal. Fig.  1, A and B show the colon histology typical 
of the germfree 21-4H and 33-3 rats,  respectively.  For com- 
parison, the normal colon histology of a nontransgenic germ- 
free LEW littermate control rat is shown in Fig.  1 C, and 
prominent colitis evident in an age-matched transgenic 21-4H 
rat born and raised with normal intestinal flora is shown in 
Fig.  1 D 
Sections of ileum or stomach were examined, respectively, 
in seven and eight germfree transgenic rats.  Mild lympho- 
cytic infiltration of the lamina propria was found in five of 
the stomachs. Two ileal specimens showed mild crypt hyper- 
plasia,  one of which was from the one rat described above 
with thickening of the intestinal wall. 
Joint Diseas~  No arthritis or other joint abnormalities were 
noted clinically at any time in the germfree rats. Ankle joints 
from four 21-4H and four 33-3 rats, 39-58 wk of age, were 
examined histologically and found to be completely normal, 
Although, in our experience, inflammatory  lesions have always 
been histologically evident in joints that showed clinical ar- 
thritis, the sensitivity of the absence of clinically evident ar- 
thritis to predict normal histology had not been determined. 
To test this, clinically normal ankle joints from the following 
rats were examined histologically:  11 line 33-3  rats,  36-57 
wk of age,  from the conventional or barrier colonies, and 
three 64-wk-old 21-4H rats transferred at 8 wk of age from 
the germfree facility to the barrier facility. No arthritis was 
found in any of these specimens. These results indicate a com- 
plete suppression  of peripheral arthritis by the germfree state. 
Tail vertebral joints were examined histologically from the 
same eight germfree rats and two of the transferred 64-wk- 
old 21-4H rats described in the previous paragraph, and from 
16 transgenic nongermfree rats,  27-57 wk of age.  One of 
the eight germfree rats and six of the 16 nongermfree rats 
showed mild periannular fibrosis. 
Cutaneous Disease.  Despite the lack of gut and joint dis- 
ease, the germfree transgenic rats developed prominent skin 
and nail lesions.  These included epidermitis and superficial 
dermatitis in tail skin (Fig. 2 A) and hyperkeratotic nail changes 
that have been previously described (2). In addition, the germ- 
free rats showed prominent alopecia associated histologically 
with folliculitis and perifolliculitis with resultant follicular 
atrophy (Fig.  2 B). This lesion also occurs with increasing 
age in the majority of nongermfree rats of the 33-3 and 21-4H 
lines (Yanagisawa,  H., J. A. Richardson, J. D. Tautog, and 
R. E. Hammer, manuscript in preparation). Comparison of 
histologic lesions in tail  skin showed no significant differ- 
ences between germfree and conventional or barrier-raised 
transgenic rats of either line (Table  1). 
Male Fertility and Genital Inflammation.  The germfree trans- 
genic males developed testicular inflammation and infertility 
similar to that previously described in nongermfree rats (2). 
This process may be a nonspecific effect of high HLA-B trans- 
gene expression,  since a similar lesion has now been observed 
as the sole pathologic manifestation of transgenic rats with 
high expression of another HLA-B gene, HLA-B7 (Maika, 
S. D., J. D. Tautog, W. A. Simmons, J. A. Richardson, and 
R. E. Hammer, manuscript in preparation). One mating be- 
tween two 33-3 germfree rats produced two offspring homo- 
zygous for the transgene locus,  as determined by quantita- 
tive hybridization of genomic DNA. The phenotype of the 
two homozygotes did not differ from that of the hemizy- 
gous germfree rats. 
Expression of HLA-B27 in Germfree Rats.  Previously we 
observed that disease susceptibility in the B27 transgenic rat 
lines correlated with high B27 expression in lymphoid tissue 
(14). To examine the possibility that the absence of gut or 
joint inflammation in the germfree rats might be associated 
2360  The Absence of Gut and Joint Disease in Germfree  B27 Rats Figure  1.  Histology of distal colon in germfree and nongermfree rats. (A) Colon ofa 52-wk-old germfree 21-4H male rat. The section shows shallow 
crypts with no inflammation.  (13) Colon of a'39-wk-old germfree 33-3 male rat, with histology similar to that shown in A. (C) Colon of a 48-wbold 
germfree nontransgenic  male 21-4H littermate,  with histology similar to that shown in A. (/9) Colon of a 52-wk-old 21-4H female rat born and raised 
in a barrier  facility. The section shows typical chronic colitis, with crypt hyperplasia, loss of mucin-containing  cells, and an inflammatory infiltrate 
in the lamina propria.  (E) Colon of a 55-wk-old 21-4H male rat germfree until age 52 wk and then housed in a conventional room for 23 d. The 
section shows early inflammatory changes. (F) Colon of a 52-wk-old 21-4H male rat germfree until age 8 wk and then housed in a barrier facility 
for 44 wk.  The section shows changes similar to those shown in/2 (A-C, E)  ￿  (D)  x73; (F)  x100. 
with diminished expression of B27, flow cytometry  was car- 
fled out simultaneously on lymphoid cells from germfree  and 
nongermfree transgenic rats. B27 surface expression in the 
germfree rats consistently  equaled or exceeded that of age- 
matched nongermfree transgenic rats with severe disease (data 
not shown). In addition, immunocytochemistry  of colon from 
transgenic germfree rats showed prominent staining for B27 
of the resident cells in the lamina propria (data not shown). 
2361  Taurog et al.  Brief Definitive Report Figtam 2.  Histopathology of skin from germffee 1327 
rats.  (.4) ~il skin of a 23-wk-old gernffree  21-4H male 
rat,  showing  epidermal hyperphsia and  inflammatory 
infiltration of the epidermis and superficial dermis (arrow- 
heads). Foiliculitis and perifolliculitis are evident in the 
dermis (astet/sk) x 57. (B) Trunk skin ofa 51-wk-old germ- 
free 33-3 female rat, showing prominent folliculitis and 
perifolliculitis (  arrou,  keads) x55. 
Suppression of  Acute Phase Response.  To apply a quantita- 
tive assessment to the suppression of inflammation by the 
germfree state,  mRNA transcripts for the acute phase reac- 
tant otl-AGP were measured in liver samples from germfree 
and nongermfree 33-3 transgenic and F344 control rats.  As 
shown in Fig. 3, the germfree rats showed reduced levels of 
oll-AGP message, compared with nongermfree transgenic 33-3 
rats. 
Raconstitution of  Germfree Rats.  To examine whether germ- 
free B27 transgenic rats develop gut or joint inflammation 
once reconstituted with gut flora, two 52-wk-old 21-4H rats 
were transferred from the germfree facility to  the conven- 
tional colony. Upon killing 23 d later, both had developed 
diarrhea,  and histologic examination of the colon showed 
inflammation (Fig. 1 E). None of seven similarly treated non- 
transgenic LEW or F344 rats showed any dinical or histo- 
logic abnormalities (transfers at ages 52-66 wk, observed at 
3-14 wk, data not shown). In addition, four 21-4H rats were 
transferred from the germfree facility to the barrier colony 
at the age of 8 wk and then killed 16-56 wk later.  All four 
showed histologic evidence of colitis (Fig.  1 F). Early colitis 
was also seen in a section of colon from one of eight trans- 
genie rats (24-38 wk) that were shipped to Dallas in non- 
germfree containers 2-3 d  before killing,  and five of these 
rats also showed mild crypt hyperplasia of the ileum (data 
not shown). 
Neurologic Disease in 21-41-1Rats.  Rats of the 21-41-I line 
consistently exhibit a neurologic lesion, beginning in the first 
month of life, resulting from failure of myelination of popu- 
lations of axons in the spinal  cord and cerebellum (2,  and 
unpublished findings). Similar lesions have been reported in 
transgenic mice expressing class I MHC genes driven by a 
Table  1.  Histologic Assessment of Skin 
Histologic appearance 
Psoriasfform 
n  Age range  Normal  lesions*  Folliculitis 
wk 
Tail skin 
21-4H  germfree  12  24-58  3  9  7~ 
21-4H  nongermfree  4w  24-64  1  2  3 
33-3  germffee  9  24-48  1  7  8 
33-3 nongermffee  9  36-40  0  5  9 
Trunk skin H 
21-4H germfree  6  52-58  1  2  5 
33-3 germfree  7  40-52  0  2  7 
* Dermatitis, acanthosis,  keratinocyte necrosis,  exocytosis, or parakeratosis. 
No follicles were evident in two of the sections. 
w These four rats were transferred from the germfree facility to the nongermfree colony 23-391  d before killing. 
[I Age-matched nongermfree specimens were not systematically examined. Lesions were similar to those seen in another study in nongermffee rats 
(Yanagisawa  et al., manuscript in preparation). 
2362  The Absence of Gut and Joint Disease in Germfree B27 Rats Figure 3.  Northern analysis showing otl-AGP mKNA and 18S KNA 
expression in livers from line 33-3 rats and nontransgenic  littermate con- 
trols. The blot was sequentially hybridized with probes for cd-AGP and 
18S KNA and quantitated by phosphorimaging. r  KNA ratios, 
expressed relative to the value for sample 9, are indicated at the bottom. 
From left to tight, lane 1: 51-wk-old 33-3 male, born and raised in a bar- 
tier facility; lane 2: 33-wk-old 33-3 female, born and raised in a barrier 
facility; lanes 3 and 4: 48-wk-old germfree 33-3 females; lane 5: 51-wk-old 
germfree 33-3 male; lanes 6 and 7: 51-wk-old germfree 33-3 females; lane 
8: 48-wk-old germfree nontransgenic  female littermate; lane 9: 57-wk-old 
nontransgenic  female littermate,  transferred at age 52 wk from germfree 
to conventional environments;  lane 10: 18-wk-old nontransgenic female 
littermate, raised in barrier facility. (GF) Germfree; (NGF)  nongermfree. 
myelin promoter (19, 20). Clinical neurologic findings in the 
germfree 21-4H rats were the same as those seen in nongerm- 
free 21-4H  rats. 
Discussion 
The germfree state protected B27 transgenic rats from gut 
and periperhal joint inflammation, but had no effect on the 
progression of skin lesions.  In nongermfree transgenic rats, 
diarrhea usually precedes onset of arthritis (2,  14), and this 
is also the sequence in enteritis-induced reactive arthritis in 
humans. Since both gut and joint inflammation were sup- 
pressed in the germfree rats, it cannot be discerned with cer- 
tainty from these experiments whether joint disease  arises 
as a consequence of an intestinal process,  or whether both 
are parallel consequences of one or more antecedent processes 
related to gut bacteria. Enteric bacterial pathogens are well 
known to trigger B27-associated rheumatic disease in humans, 
but  a direct role for normal gut flora has not established. 
The results reported here provide direct evidence that com- 
mensal enteric bacteria play a critical role in the pathogenesis 
of B27-assodated rheumatic disease.  The data also support 
the hypothesis that commensal bacteria play an important 
role in the pathogenesis of idiopathic inflammatory bowel 
disease  (21).  This is also  supported by the report that the 
spontaneous colitis recently described in IL-2-deficient mice 
was absent in three of three such mice observed in the germ- 
free state through 5 mo of age (22). 
The role of the gut flora in axial arthropathy is somewhat 
more difficult to assess from these experiments since the only 
lesions found in any of the rats examined were mild and not 
necessarily related to inflammation. Lesions were not entirely 
absent from the germfree rats, but were found with higher 
prevalence in the nongermfree transgenic rats examined. In 
humans,  ankylosing spondylitis is  highly associated with 
inflammatory bowel disease, but its course is usually inde- 
pendent of the state of the bowel disease, whereas peripheral 
arthritis tends to parallel the activity of bowel inflammation 
(23). Similarly, treatment of ankylosing spondylitis patients 
with  sulfasalazine,  an  agent  with  documented efficacy in 
suppressing inflammatory bowel disease, has shown a bene- 
ficial  effect more consistently on peripheral than on axial 
arthropathy (24). 
These results indicate that the gut flora do not contribute 
significantly to the pathogenesis of the skin and nail lesions 
of the B27 rats,  in contrast to the effect on gut and joint 
disease. However, the germfree rats were not housed in an 
antigen-free environment, and it remains possible that prod- 
ucts of nonviable microorganisms might have played a role 
in the pathogenesis of the cutaneous lesions.  This explana- 
tion might also account for the subtle differences in gastroin- 
testinal histology observed between transgenic and nontrans- 
genic germfree rats. Alternatively, these findings may be solely 
manifestations of transgene expression, as we suspect to be 
the case for the noninflammatory neurologic lesion of the 
21-4H line and perhaps also for the male genital inflamma- 
tion of both lines. 
Suppression of gut inflammation was rapidly reversed by 
removal from the germfree state.  No arthritis  was seen in 
the rats with a restored gut flora, but comparatively few rats 
were examined and the period of observation for some of 
them was quite short. It thus cannot be concluded from this 
that arthritis would not appear in this setting if it were sys- 
tematically sought. Rather, the data suggest that reconstitu- 
tion experiments with defined bacteria will permit identifica- 
tion of the bacterial components critical to the B27-related 
disease process. 
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